1153 CYCLOPHILIN INHIBITOR ALISPORIVIR (ALV) COMBINATIONS WITH DIRECT ACTING ANTIVIRALS REVEAL STRONG SYNERGISTIC ANTI-HCV EFFECTSJavier García-Rivera, Philippe Gallay, Udayan Chatterji|Journal of Hepatology|2013Cited by 3
841 BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HCV INFECTIONSteven J. Moss, Matthew A. Gregory, Javier García-Rivera et al.|Journal of Hepatology|2012Cited by 2